Keyphrases
New Drugs
100%
Multidrug-resistant Tuberculosis (MDR-TB)
100%
Drug Sensitivity
100%
Benzo
100%
Macozinone
100%
Nitro
66%
13C NMR
66%
Mycobacterium Tuberculosis (M. tb)
33%
Phase I Clinical Trial
33%
Tuberculosis
33%
Etiological Agents
33%
Infection-related Mortality
33%
Structural Characterization
33%
X-ray Crystallography
33%
1H nuclear Magnetic Resonance (1H NMR)
33%
Spectroscopic Characterization
33%
One-group
33%
N Atoms
33%
Piperazine
33%
Electron-deficient
33%
4H-1
33%
Chair Conformation
33%
IR Rays
33%
Piperazine Ring
33%
Medicine and Dentistry
Piperazine
100%
Macozinone
100%
Drug Resistant Tuberculosis
100%
Pathogen
33%
Clinical Trial
33%
Infection
33%
Mycobacterium Tuberculosis
33%
Proton Nuclear Magnetic Resonance
33%
Carbon Nuclear Magnetic Resonance
33%
X-Ray Crystallography
33%
Chemistry
Crystal Structure
100%
Piperazine
100%
new drug
100%
1H NMR Spectroscopy
50%
13C NMR Spectroscopy
50%
High Resolution Mass Spectrometry (HRMS)
50%
X-Ray Crystallography
50%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Resistant Tuberculosis
100%
Macozinone
100%
Piperazine
100%
Clinical Trial
33%
Infectious Agent
33%
Infection
33%
Carbon 13
33%
Mycobacterium Tuberculosis
33%